NCT05122221 2022-06-28CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck CancersCorregene Biotechnology Co., LtdPhase 1 Unknown12 enrolled
NCT02280811 2017-09-06T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed12 enrolled 19 charts